True Wealth Design’s SpringWorks Therapeutics SWTX Stock Holding History

True Wealth Design’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7	Closed	-$329	–	2879
2025 Q2	$329	Sell	7 -73	-91%	-$3.25K	﹤0.01%	1894
2025 Q1	$3.53K	Buy	+80	New	+$3.68K	﹤0.01%	799

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

True Wealth Design's SWTX Position: Q3 2025 in Review

True Wealth Design sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 7 shares — an estimated $329 sold.

True Wealth Design first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $3.53K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

True Wealth Design reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
True Wealth Design sold 7 SpringWorks Therapeutics shares in Q3 2025, an estimated $329.
True Wealth Design first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
True Wealth Design's SpringWorks Therapeutics position peaked at $3.53K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.